Analysis: Bayer shares about to turn around? Experts advise caution!
According to a report from stock3.com, things are currently not looking rosy for investors and traders invested in Bayer shares. The share is in a dynamic downward trend and has continuously lost value in recent weeks. Another cause for concern is the seasonal weakness forecast over the next 31-60 days. In addition, Bayer AG's quarterly figures are due, which may bring additional volatility and uncertainty. The factors mentioned suggest that Bayer shares may be oversold, which could lead to stabilization in the short term. However, investors should be careful and not make hasty...

Analysis: Bayer shares about to turn around? Experts advise caution!
According to a report by stock3.com, things are currently not looking rosy for investors and traders who are invested in Bayer shares. The share is in a dynamic downward trend and has continuously lost value in recent weeks. Another cause for concern is the seasonal weakness forecast over the next 31-60 days. In addition, Bayer AG's quarterly figures are due, which may bring additional volatility and uncertainty.
The factors mentioned suggest that Bayer shares may be oversold, which could lead to stabilization in the short term. However, investors should be careful and not make hasty decisions, especially with a view to a medium to long-term trend reversal. If the sellers continue to have the upper hand, the share price could fall to EUR 35.50-EUR 32.60.
The information from the article suggests that Bayer shares are facing difficult times in the short term, reinforced by the seasonal trend and upcoming quarterly results. It is likely that investors and traders will face continued volatility and uncertainty over the next few weeks. Although there are opportunities for a temporary recovery, the factors mentioned suggest that it is currently advisable to be cautious and not make hasty decisions.
Read the source article at stock3.com